"Beckman Coulter" DxH 500 Series Hemocytolytic Agent (Unsterilized) - Taiwan Registration 3e360ba2121dc6c3657e8e245c8fd705
Access comprehensive regulatory information for "Beckman Coulter" DxH 500 Series Hemocytolytic Agent (Unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 3e360ba2121dc6c3657e8e245c8fd705 and manufactured by BIT GROUP FRANCE;; BECKMAN COULTER IRELAND INC.. The authorized representative in Taiwan is BECKMAN COULTER TAIWAN INC., TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
3e360ba2121dc6c3657e8e245c8fd705
DHA09401823000
Product Details
Limited to the classification and grading management measures for medical devices, the first level identification range of "red blood cell lytic agent (B.8540)".
B Hematology, pathology, and genetics
B.8540 ็ด ่ก็ๆบถ่งฃๅ
Input;; Contract manufacturing
Dates and Status
Aug 23, 2017
Aug 23, 2027

